Home » Topics » BioWorld Science

BioWorld Science
RSS

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

July 17, 2018

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

July 17, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

Concentric Analgesics initiates phase II trial of CA-008 to treat postsurgical pain

July 17, 2018

Rimeporide well tolerated in boys with Duchenne muscular dystrophy

July 17, 2018

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

July 17, 2018

Animal model of HAAF provides insight on pathological process of the disease

July 17, 2018

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...